HealthWarehouse.com Inc. reported robust financial results for the second quarter of 2025, showcasing a significant 182% increase in net sales, which totaled $15.7 million. This surge was primarily driven by a 495% growth in partner services revenues. The company recorded a net income of $228,000 for the quarter, a notable turnaround from a net loss of $344,000 in the same period the previous year. HealthWarehouse.com also reported an Adjusted EBITDA of $568,000, which marks a substantial improvement compared to the $25,000 reported for the second quarter of 2024. HealthWarehouse.com operates as a technology company focusing on healthcare e-commerce, providing prescription and over-the-counter medications across all 50 states as an Approved Digital Pharmacy through the National Association of Boards of Pharmacy (NABP). The company emphasizes its commitment to enhancing accessibility and reducing costs of healthcare products for consumers and business partners nationwide. No future financial guidance or outlook was provided in the report.